XENETIC BIOSCIENCES, INC. (XBIO) Return on equity 2016–2025
XENETIC BIOSCIENCES, INC. (XBIO) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-36.2%FY2025 · since FY2016: -335.2% → -36.2%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -36.2% | +29.7 pp |
| FY2024 | -65.9% | -23.7 pp |
| FY2023 | -42.2% | +5.8 pp |
| FY2022 | -48.0% | -17.3 pp |
| FY2021 | -30.7% | +58.5 pp |
| FY2020 | -89.2% | -15.0 pp |
| FY2019 | -74.2% | -0.6 pp |
| FY2018 | -73.6% | -48.5 pp |
| FY2017 | -25.1% | +310.1 pp |
| FY2016 | -335.2% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice